Cargando…

CD52-targeted depletion by Alemtuzumab ameliorates allergic airway hyperreactivity and lung inflammation

Allergic asthma is a chronic inflammatory disorder associated with airway hyperreactivity (AHR) whose global prevalence is increasing at an alarming rate. Group 2 innate lymphoid cells (ILC2s) and T helper 2 (T(H)2) cells are producers of type 2 cytokines, which may contribute to development of AHR....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shafiei-Jahani, Pedram, Helou, Doumet Georges, Hurrell, Benjamin P., Galle-Treger, Lauriane, Howard, Emily, Quach, Christine, Painter, Jacob D., Fung, Marshall, Lo, Richard, Allayee, Hooman, Akbari, Omid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225558/ https://www.ncbi.nlm.nih.gov/pubmed/33731828 http://dx.doi.org/10.1038/s41385-021-00388-5

Ejemplares similares

Distinct Roles of LFA-1 and ICAM-1 on ILC2s Control Lung Infiltration, Effector Functions, and Development of Airway Hyperreactivity
por: Hurrell, Benjamin P., et al.
Publicado: (2020)

TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity
por: Hurrell, Benjamin P., et al.
Publicado: (2019)

PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity
por: Helou, Doumet Georges, et al.
Publicado: (2020)

Orai inhibition modulates pulmonary ILC2 metabolism and alleviates airway hyperreactivity in murine and humanized models
por: Howard, Emily, et al.
Publicado: (2023)

CD200–CD200R immune checkpoint engagement regulates ILC2 effector function and ameliorates lung inflammation in asthma
por: Shafiei-Jahani, Pedram, et al.
Publicado: (2021)

DR3 stimulation of adipose resident ILC2s ameliorates type 2 diabetes mellitus
por: Shafiei-Jahani, Pedram, et al.
Publicado: (2020)

Autophagy impairment in liver CD11c(+) cells promotes non-alcoholic fatty liver disease through production of IL-23
por: Galle-Treger, Lauriane, et al.
Publicado: (2022)

PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability
por: Hurrell, Benjamin P., et al.
Publicado: (2022)

PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma
por: Howard, Emily, et al.
Publicado: (2021)

Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity
por: Galle-Treger, Lauriane, et al.
Publicado: (2016)

Role of Autophagy in Lung Inflammation
por: Painter, Jacob D., et al.
Publicado: (2020)

A GWAS approach identifies Dapp1 as a determinant of air pollution-induced airway hyperreactivity
por: Maazi, Hadi, et al.
Publicado: (2019)

Enhancing autophagy in CD11c(+) antigen-presenting cells as a therapeutic strategy for acute respiratory distress syndrome
por: Quach, Christine, et al.
Publicado: (2023)

Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma
por: Hurrell, Benjamin P., et al.
Publicado: (2018)

Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation
por: Lewis, Gavin, et al.
Publicado: (2019)

Feasibility of quantifying change in immune white cells in abdominal adipose tissue in response to an immune modulator in clinical obesity
por: Sattler, Fred R., et al.
Publicado: (2020)

Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma
por: Han, Yi, et al.
Publicado: (2020)

Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes
por: Galle-Treger, Lauriane, et al.
Publicado: (2019)

Near-roadway air pollution, immune cells and adipokines among obese young adults
por: Rahman, Md Mostafijur, et al.
Publicado: (2022)

Clinical pharmacology of alemtuzumab, an anti‐CD52 immunomodulator, in multiple sclerosis
por: Li, Z., et al.
Publicado: (2018)

Nasal hyperreactivity and inflammation in allergic rhinitis
por: Garrelds, I. M., et al.
Publicado: (1996)

Correction for Hirose et al., “Impact of a Demyelination-Inducing Central Nervous System Virus on Expression of Demyelination Genes in Type 2 Lymphoid Cells”
por: Hirose, Satoshi, et al.
Publicado: (2021)

Analysis of the interplay between hepatitis B virus-positive hepatocytes and Kupffer cells ex vivo using mice as a model
por: Li, Yumei, et al.
Publicado: (2022)

CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment
por: Hotta, Ryuichi, et al.
Publicado: (2016)

Alemtuzumab: COVID-19 infection and severe depletion of T-lymphocyte: case report
Publicado: (2020)

Actual therapeutic management of allergic and hyperreactive nasal disorders
por: Rudack, Claudia
Publicado: (2004)

Both cladribine and alemtuzumab may effect MS via B-cell depletion
por: Baker, David, et al.
Publicado: (2017)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Bronchial hyperreactivity and spirometric impairment in polysensitized patients with allergic rhinitis
por: Ciprandi, Giorgio, et al.
Publicado: (2004)

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52(+) T-cell malignancies
por: Miljkovic, Milos D., et al.
Publicado: (2022)

Type 2 Innate Lymphoid Cells Induce CNS Demyelination in an HSV-IL-2 Mouse Model of Multiple Sclerosis
por: Hirose, Satoshi, et al.
Publicado: (2020)

Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis
por: Goischke, Hans-Klaus
Publicado: (2019)

The polymeric mucin Muc5ac is required for allergic airway hyperreactivity
por: Evans, Christopher M., et al.
Publicado: (2015)

Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells
por: Lim, Che K, et al.
Publicado: (2008)

CD8α(+)β(−) and CD8α(+)β(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyperreactivity
por: Lombardi, Vincent, et al.
Publicado: (2012)

Association of insulin resistance with bronchial hyperreactivity
por: Kim, Kyung-Mook, et al.
Publicado: (2014)

To Have and Have Not: Intrinsic Platelet Hyperreactivity?
por: Laine, Marc, et al.
Publicado: (2018)

Mitigating alemtuzumab-associated autoimmunity in MS: A “whack-a-mole” B-cell depletion strategy
por: Meltzer, Ethan, et al.
Publicado: (2020)

Depletion of CD52‐positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune‐tolerance promoting CD8 T‐cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis
por: von Kutzleben, Stephanie, et al.
Publicado: (2017)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ub6rda1hroesrd0knov59k9145